Trending
LeukO 2026 to Unite the Global Leukemia Community This September is trending now Lab Chemical Exposure, Diet Tied to Young Scientists' Health is trending now Rising Seas Not the Only Threat to Coastal Cities is trending now Myles Lewis-Skelly transfer news: Chelsea and Man Utd turn down intermediary offer to sig… is trending now Somali denied World Cup ‘proud’ to referee PSG vs Villa in UEFA Super Cup is trending now PSG vs Aston Villa: UEFA Super Cup – prediction, lineups, teams is trending now Bukky Wright Calls Out Nollywood Actors Who Show Up Five Hours Late to Set is trending now Mama G Shares Reasons She Always Plays Witch Roles in Nollywood Movies: "Na That Eye I De… is trending now "Big things are coming": 70 vendors ready for Adedimeji's triplets' celebration is trending now Ex-gang leader faces trial over 1996 Tupac Shakur murder is trending now Aurodig targets data-conscious mobile users with new approach to streaming is trending now Pin Up Casino Kenya: Which Games Kenyans Are Choosing in 2026 is trending now LeukO 2026 to Unite the Global Leukemia Community This September is trending now Lab Chemical Exposure, Diet Tied to Young Scientists' Health is trending now Rising Seas Not the Only Threat to Coastal Cities is trending now Myles Lewis-Skelly transfer news: Chelsea and Man Utd turn down intermediary offer to sig… is trending now Somali denied World Cup ‘proud’ to referee PSG vs Villa in UEFA Super Cup is trending now PSG vs Aston Villa: UEFA Super Cup – prediction, lineups, teams is trending now Bukky Wright Calls Out Nollywood Actors Who Show Up Five Hours Late to Set is trending now Mama G Shares Reasons She Always Plays Witch Roles in Nollywood Movies: "Na That Eye I De… is trending now "Big things are coming": 70 vendors ready for Adedimeji's triplets' celebration is trending now Ex-gang leader faces trial over 1996 Tupac Shakur murder is trending now Aurodig targets data-conscious mobile users with new approach to streaming is trending now Pin Up Casino Kenya: Which Games Kenyans Are Choosing in 2026 is trending now
Spokane

Next-Gen Reusable HST Boasts Immediate Access to Results

Next-Gen Reusable HST Boasts Immediate Access to Results

The FDA-cleared device is designed to be a compatible platform to support future accessories.

The FDA-cleared device is designed to be a compatible platform to support future accessories.

Key takeaways:

  • WatchPAT 400 is a new FDA-cleared home sleep test that utilizes a smartphone app for immediate access to study results.
  • The reusable device captures seven channels, detects central sleep apnea and atrial fibrillation, and boasts an 89% correlation to polysomnography in AHI, according to ZOLL Itamar.
  • It is commercially available in the US and the EU.

At SLEEP 2026, ZOLL Itamar revealed the reusable WatchPAT 400, a new US Food and Drug Administration (FDA)-cleared home sleep test designed to offer a streamlined, app-connected experience for sleep diagnostics.

The device, which received FDA 510(k) clearance in September, builds on the efficiency of the reusable WatchPAT 300 while incorporating the simplicity and control of the disposable WatchPAT ONE, according to ZOLL Itamar. It is designed to be a compatible platform to support future accessories.

According to the company, the device utilizes a smartphone app that allows immediate access to sleep results after study completion, helping to improve both operational efficiency and patient compliance.

Key features of the WatchPAT 400 include:

  • Provides immediate access to study results with a smartphone application after study completion.
  • Features an easy setup process with the WatchPAT app and three points of contact.
  • Captures seven channels with four respiratory indices.
  • Demonstrates an 89% correlation to polysomnography in apnea-hypopnea index (AHI), according to the company.
  • Utilizes total sleep time for AHI calculation, similar to other WatchPAT devices.
  • Detects apnea/hypopnea events and differentiates central sleep apnea events, with the added value of detecting atrial fibrillation events and premature beats.
  • Includes hypoxic burden in the latest sleep reports.
  • Utilizes SleePATh functionality for increased patient communication and compliance.

The WatchPAT 400 currently commercially available in the United States and European Union.


More in ZOLL Itamar:

View original source →

Related